Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Teva receives FDA approval for generic estazolam

July 15, 1997

FDA approves antibacterial generic from Mylan

July 14, 1997

Mylan antianxiety/antipsychotic generic approved by FDA

July 14, 1997

Profile of a new formulation of eperisone hydrochloride

July 14, 1997

Knoll receives FDA approval to market Mavik for new indication

July 14, 1997

Ergo Science's Ergoset enters phase II/III trials in obesity

July 14, 1997

Mylan, Purepac and ESI Lederle report FDA generic approvals

July 14, 1997

Once-daily extended-release venlafaxine evaluated in depression

July 11, 1997

Generic etodolac approved by FDA

July 11, 1997

Sparta's Spartaject busulfan enters phase I

July 11, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...